Lymphocytic esophagitis: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Lymphocytic_esophagitis_histology.jpg|Histological image showing lymphocytic esophagitis | |||
File:Food_bolus_obstruction.jpg|Endoscopic view of food bolus obstruction | |||
File:Lymphocytic_esophagitis_endoscopy.jpg|Endoscopic image of lymphocytic esophagitis | |||
</gallery> | |||
Revision as of 04:04, 18 February 2025
Lymphocytic esophagitis (LE) is a rare, poorly understood medical condition that affects the esophagus. It is characterized by an increased number of lymphocytes in the esophagus without the common features of gastroesophageal reflux disease (GERD).
Symptoms
The symptoms of lymphocytic esophagitis can vary greatly among patients. Some may experience no symptoms at all, while others may have severe symptoms. Common symptoms include dysphagia (difficulty swallowing), heartburn, and chest pain.
Causes
The exact cause of lymphocytic esophagitis is unknown. However, it is thought to be related to an immune response, possibly triggered by an allergy or autoimmune disease.
Diagnosis
Diagnosis of lymphocytic esophagitis is typically made through an endoscopy and biopsy of the esophagus. The presence of a high number of lymphocytes in the esophagus, without other signs of GERD, is indicative of LE.
Treatment
Treatment for lymphocytic esophagitis is largely symptomatic. This may include dietary changes, medications to reduce stomach acid, and in severe cases, corticosteroids or other immunosuppressive drugs.
Prognosis
The long-term prognosis for individuals with lymphocytic esophagitis is generally good. However, the condition can cause significant discomfort and impact quality of life. Ongoing research is needed to better understand this condition and develop more effective treatments.


